| 臺大學術典藏 |
2022-03-10T07:58:41Z |
Granulosa cell-derived induced pluripotent stem cells exhibit pro-Trophoblastic differentiation potential
|
Chuang C.-Y.; Huang M.-C.; Chen H.-F.; LI-HUI TSENG; Yu C.-Y.; Stone L.; Huang H.-P.; Ho H.-N.; Kuo H.-C. |
| 臺大學術典藏 |
2021-06-03T06:50:18Z |
Epithelial cell adhesion molecule (EpCAM) complex proteins promote transcription factor-mediated pluripotency reprogramming
|
HSIANG-PO HUANG; Chen P.-H.; Yu C.-Y.; Chuang C.-Y.; Stone L.; Hsiao W.-C.; Li C.-L.; Tsai S.-C.; Chen K.-Y.; Chen H.-F.; Ho H.-N.; Kuo H.-C. |
| 臺大學術典藏 |
2021-06-03T06:50:17Z |
Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification
|
HSIANG-PO HUANG; Chen P.-H.; Hwu W.-L.; Chuang C.-Y.; Chien Y.-H.; Stone L.; Chien C.-L.; Li L.-T.; Chiang S.-C.; Chen H.-F.; Ho H.-N.; Chen C.-H.; Kuo H.-C. |
| 臺大學術典藏 |
2021-06-03T06:50:15Z |
Granulosa cell-derived induced pluripotent stem cells exhibit pro-Trophoblastic differentiation potential
|
Chuang C.-Y.; Huang M.-C.; Chen H.-F.; Tseng L.-H.; Yu C.-Y.; Stone L.; HSIANG-PO HUANG; Ho H.-N.; Kuo H.-C. |
| 臺大學術典藏 |
2021-06-03T06:50:12Z |
Using human Pompe disease-induced pluripotent stem cell-derived neural cells to identify compounds with therapeutic potential
|
Hsiang-Po Huang;Chiang W.;Stone L.;Kang C.-K.;Chuang C.-Y.;Kuo H.-C.; HSIANG-PO HUANG; Chiang W.; Stone L.; Kang C.-K.; Chuang C.-Y.; Kuo H.-C. |
| 臺大學術典藏 |
2020-12-24T06:16:52Z |
Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification
|
Huang H.-P.; Chen P.-H.; Hwu W.-L.; Chuang C.-Y.; YIN-HSIU CHIEN; Stone L.; Chien C.-L.; Li L.-T.; Chiang S.-C.; Chen H.-F.; Ho H.-N.; Chen C.-H.; Kuo H.-C. |
| 臺大學術典藏 |
2020-12-16T02:25:40Z |
Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification
|
Huang H.-P.;Chen P.-H.;Wuh-Liang Hwu;Chuang C.-Y.;Chien Y.-H.;Stone L.;Chien C.-L.;Li L.-T.;Chiang S.-C.;Chen H.-F.;Ho H.-N.;Chen C.-H.;Kuo H.-C.; Huang H.-P.; Chen P.-H.; WUH-LIANG HWU; Chuang C.-Y.; Chien Y.-H.; Stone L.; Chien C.-L.; Li L.-T.; Chiang S.-C.; Chen H.-F.; Ho H.-N.; Chen C.-H.; Kuo H.-C. |
| 臺大學術典藏 |
2020-12-16T02:25:36Z |
Human pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification
|
Huang H.-P.; Chen P.-H.; WUH-LIANG HWU; Chuang C.-Y.; Chien Y.-H.; Stone L.; Chien C.-L.; Li L.-T.; Chiang S.-C.; Chen H.-F.; Ho H.-N.; Chen C.-H.; Kuo H.-C. |
| 臺大學術典藏 |
2020-02-27T01:50:09Z |
Human pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification
|
Huang H.-P.;Chen P.-H.;Hwu W.-L.;Chuang C.-Y.;Chien Y.-H.;Stone L.;Chung-Liang Chien;Li L.-T.;Chiang S.-C.;Chen H.-F.;Ho H.-N.;Chen C.-H.;Kuo H.-C.; Huang H.-P.; Chen P.-H.; Hwu W.-L.; Chuang C.-Y.; Chien Y.-H.; Stone L.; CHUNG-LIANG CHIEN; Li L.-T.; Chiang S.-C.; Chen H.-F.; Ho H.-N.; Chen C.-H.; Kuo H.-C. |
| 臺大學術典藏 |
2020-02-27T01:50:09Z |
Human pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification
|
Huang H.-P.;Chen P.-H.;Hwu W.-L.;Chuang C.-Y.;Chien Y.-H.;Stone L.;Chung-Liang Chien;Li L.-T.;Chiang S.-C.;Chen H.-F.;Ho H.-N.;Chen C.-H.;Kuo H.-C.; Huang H.-P.; Chen P.-H.; Hwu W.-L.; Chuang C.-Y.; Chien Y.-H.; Stone L.; CHUNG-LIANG CHIEN; Li L.-T.; Chiang S.-C.; Chen H.-F.; Ho H.-N.; Chen C.-H.; Kuo H.-C. |
| 臺大學術典藏 |
2020-02-27T01:50:09Z |
Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification
|
Huang H.-P. ;Chen P.-H. ;Hwu W.-L. ;Chuang C.-Y. ;Chien Y.-H. ;Stone L. ;Chung-Liang Chien ;Li L.-T. ;Chiang S.-C. ;Chen H.-F. ;Ho H.-N. ;Chen C.-H. ;Kuo H.-C.; Huang H.-P.; Chen P.-H.; Hwu W.-L.; Chuang C.-Y.; Chien Y.-H.; Stone L.; CHUNG-LIANG CHIEN; Li L.-T.; Chiang S.-C.; Chen H.-F.; Ho H.-N.; Chen C.-H.; Kuo H.-C. |
| 臺大學術典藏 |
2020-02-27T01:50:09Z |
Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification
|
Huang H.-P. ;Chen P.-H. ;Hwu W.-L. ;Chuang C.-Y. ;Chien Y.-H. ;Stone L. ;Chung-Liang Chien ;Li L.-T. ;Chiang S.-C. ;Chen H.-F. ;Ho H.-N. ;Chen C.-H. ;Kuo H.-C.; Huang H.-P.; Chen P.-H.; Hwu W.-L.; Chuang C.-Y.; Chien Y.-H.; Stone L.; CHUNG-LIANG CHIEN; Li L.-T.; Chiang S.-C.; Chen H.-F.; Ho H.-N.; Chen C.-H.; Kuo H.-C. |
| 臺大學術典藏 |
2020-02-17T07:43:37Z |
Epithelial cell adhesion molecule (EpCAM) complex proteins promote transcription factor-mediated pluripotency reprogramming
|
Kuo H.-C.; HONG-NERNG HO; Chen H.-F; Chen K.-Y; Tsai S.-C; Li C.-L; Hsiao W.-C; Stone L; Chuang C.-Y; Yu C.-Y; Chen P.-H; Huang H.-P |
| 臺大學術典藏 |
2020-02-17T07:43:36Z |
Human pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification
|
Huang H.-P; Chen P.-H; Hwu W.-L; Chuang C.-Y; Chien Y.-H; Stone L; Chien C.-L; Li L.-T; Chiang S.-C; Chen H.-F; HONG-NERNG HO; Chen C.-H; Kuo H.-C. |
| 臺大學術典藏 |
2020-02-17T07:43:35Z |
LHX2 regulates the neural differentiation of human embryonic stem cells via transcriptional modulation of PAX6 and CER1
|
Hou P.-S; Chuang C.-Y; Kao C.-F; Chou S.-J; Stone L; HONG-NERNG HO; Chien C.-L; Kuo H.-C. |
| 臺大學術典藏 |
2020-02-17T07:43:31Z |
Granulosa cell-derived induced pluripotent stem cells exhibit pro-Trophoblastic differentiation potential
|
Chuang C.-Y; Huang M.-C; Chen H.-F; Tseng L.-H; Yu C.-Y; Stone L; Huang H.-P; HONG-NERNG HO; Kuo H.-C. |
| 臺大學術典藏 |
2018-09-10T09:21:28Z |
Meiotic competent human germ cell-like cells derived from human embryonic stem cells induced by BMP4/WNT3A signaling and OCT4/EpCAM (epithelial cell adhesion molecule) selection
|
Chuang, C.-Y.;Lin, K.-I.;Hsiao, M.;Stone, L.;Chen, H.-F.;Huang, Y.-H.;Lin, S.-P.;Ho, N.-N.;Kuo, H.-C.; Chuang, C.-Y.; Lin, K.-I.; Hsiao, M.; Stone, L.; Chen, H.-F.; Huang, Y.-H.; Lin, S.-P.; Ho, N.-N.; Kuo, H.-C.; HSIN-FU CHEN; Lin, Shau-Ping |
| 臺大學術典藏 |
2018-09-10T09:21:28Z |
Meiotic competent human germ cell-like cells derived from human embryonic stem cells induced by BMP4/WNT3A signaling and OCT4/EpCAM (epithelial cell adhesion molecule) selection
|
Chuang, C.-Y.;Lin, K.-I.;Hsiao, M.;Stone, L.;Chen, H.-F.;Huang, Y.-H.;Lin, S.-P.;Ho, N.-N.;Kuo, H.-C.; Chuang, C.-Y.; Lin, K.-I.; Hsiao, M.; Stone, L.; Chen, H.-F.; Huang, Y.-H.; Lin, S.-P.; Ho, N.-N.; Kuo, H.-C.; HSIN-FU CHEN; Lin, Shau-Ping |
| 臺大學術典藏 |
2012 |
Human pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification
|
Huang H.-P.; Chen P.-H.; Hwu W.-L.; Chuang C.-Y.; YIN-HSIU CHIEN; Stone L.; Chien C.-L.; Li L.-T.; Chiang S.-C.; Chen H.-F.; Ho H.-N.; Chen C.-H.; Kuo H.-C. |
| 臺大學術典藏 |
2011 |
Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification
|
Huang H.-P; Chen P.-H; Hwu W.-L; Chuang C.-Y; Chien Y.-H; Stone L; Chien C.-L; Li L.-T; Chiang S.-C; Chen H.-F; HONG-NERNG HO; Chen C.-H; Kuo H.-C. |
